Cited by 361Liver physiology and pathologyWnt/β-catenin signaling in development and cancerOrgan Transplantation Techniques and Outcomes

Conditional Deletion of β-Catenin Reveals Its Role in Liver Growth and Regeneration

Open access
Tan, Xinping, Behari, Jaideep, Cieply, Benjamin, Michalopoulos, George K., Monga, Satdarshan P.S.·2006·Gastroenterology

Abstract

Background & aims The Wnt/beta-catenin pathway plays a role in liver growth and development. To address this conclusively, we used a conditional knockout approach to delete beta-catenin in the liver. Methods Floxed beta-catenin (exons 2-6) mice were intercrossed with Albumin-Cre recombinase transgenic mice; considerable beta-catenin deletion was evident 15 days after birth by Western blot and immunohistochemistry analyses. Results Although these mice were viable, there was a significant decrease in their liver weight/body weight ratio by 14% at 1 month and 28%-35% by 2-6 months of age, which was sustained throughout their normal life span. There was an accompanying decrease in basal hepatocyte proliferation showed by Ki-67 staining. Additional analysis revealed several known and novel genes to be down-regulated in these mice that play a role in normal liver homeostasis. When subjected to two-thirds partial hepatectomy, the Ctnnb1(loxp/loxp); Alb-Cre(+/-) mice were sick and lethargic, especially during the first 2-3 days only. These mice display a 2-fold decrease in the number of Ki-67- or PCNA-positive cells at the time of peak hepatocyte proliferation at 40 hours, which coincided with decreased cyclin A, D, and E expression. However, a rebound increase in hepatocyte proliferation was evident in the knockout mice at 3 days. Also, increased apoptosis was observed in the knockout livers during regeneration at all stages. Conclusions Thus, beta-catenin is essential for normal liver growth and development. Also, although regeneration is delayed in the absence of beta-catenin, it does occur suboptimally, showing its redundancy in the liver.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2006.08.042

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mice with hepatocyte-specific deletion of Lgr4 alone, Lgr4 plus Lgr5 or β-catenin displayed alterations in liver size, zonation and regeneration, including hyperproliferation at late timepoints, similar to HSC-depleted mice.

    “Notably, mice with hepatocyte-specific deletion of the RSPO3 receptors Lgr4 alone, Lgr4 plus Lgr5 or their downstream target β-catenin displayed alterations in liver size, zonation and regeneration, including hyperproliferation at late timepoints, similar to HSC-depleted mice24,25.”

    From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [25]

    For the β-catenin deletion portion of the jointly cited sentence, the paper reports a lower liver-weight/body-weight ratio (Figure 2 caption), altered regeneration, and more Ki-67-positive hepatocytes than controls at 14 days after hepatectomy (Figure 7 caption; page unavailable). It reports reduced glutamine synthetase and other gene-expression changes, but the passages do not establish altered spatial liver zonation. The late proliferation finding is also limited: the Results say that only a few knockout hepatocytes remained Ki-67-positive. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • HSC-derived RSPO3 critically impacts liver size, zonation, metabolism, regeneration and injury.

    “The critical impact of HSC-derived RSPO3 on liver size, zonation, metabolism, regeneration and injury matches findings in mice with hepatocyte-specific deletion of β-catenin or LGR4/524,25,34–39, rendering RSPO3–LGR4-mediated HSC–hepatocyte communication a gatekeeper of liver function in health and disease.”

    From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [25]

    The paper reports that hepatocyte-specific β-catenin deletion reduces liver size, alters expression of metabolic enzymes, increases apoptosis, and delays regeneration after partial hepatectomy (Discussion; Differential Expression of Cytochrome P450 Enzymes; Conditional Null Mice After Two-Thirds Hepatectomy; page numbers unavailable). These findings support part of the cited comparison, but our copy does not establish effects on liver zonation or injury more broadly. It does not study HSC-derived RSPO3 or LGR4; the citing sentence does not attribute those experiments to this paper. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • RSPO3-LGR4-mediated HSC-hepatocyte communication is a gatekeeper of liver function in health and disease.

    “The critical impact of HSC-derived RSPO3 on liver size, zonation, metabolism, regeneration and injury matches findings in mice with hepatocyte-specific deletion of β-catenin or LGR4/524,25,34–39, rendering RSPO3–LGR4-mediated HSC–hepatocyte communication a gatekeeper of liver function in health and disease.”

    From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [25]

    The paper’s Discussion reports smaller livers and delayed, suboptimal regeneration after hepatocyte β-catenin deletion; its gene-array findings also show changes in metabolic genes. These support much of the cited comparison, but the copy does not establish altered liver zonation or a general response to injury beyond partial hepatectomy. The concluding RSPO3–LGR4 gatekeeper interpretation is the citing authors’ inference, not a finding attributed to this source. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Hepatocytes in the postnatal liver expand rapidly in a Wnt/β-catenin signaling-dependent way.

    “Hepatocytes in the postnatal liver expand rapidly in a Wnt/β-catenin signaling-dependent way (12–16).”
  • HSC-depleted livers exhibited compensatory hyperproliferation at later stages while HSC depletion persisted.

    “Like other mice with impaired liver regeneration24,25, HSC-depleted livers exhibited compensatory hyperproliferation at later stages, while HSC depletion persisted (Extended Data Fig. 1f).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997;11:3286 -3305.
  2. Haegel H, Larue L, Ohsugi M, Fedorov L, Herrenknecht K, Kemler R. Lack of beta-catenin affects mouse development at gastrula- tion. Development 1995;121:3529 -3537.
  3. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, Boussadia O, Kemler R. Inactivation of the beta- catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. De- velopment 2001;128:1253-1264.
  4. Armstrong DD, Wong VL, Esser KA. Expression of {beta}-catenin is necessary for physiological growth of adult skeletal muscle. Am J Physiol 2006;291:C185-C188.
  5. Miyoshi K, Shillingford JM, Le Provost F, Gounari F, Bronson R, von Boehmer H, Taketo MM, Cardiff RD, Hennighausen L, Khazaie K. Activation of beta-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epider- mis and squamous metaplasias. Proc Natl Acad Sci U S A 2002; 99:219 -224.
  6. Willert K, Nusse R. Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 1998;8:95-102.
  7. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004;303:1483-1487.
  8. van Es JH, Barker N, Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 2003;13:28 -33.
  9. Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 2001;33:1098 -1109.
  10. Sodhi D, Micsenyi A, Bowen WC, Monga DK, Talavera JC, Monga SP. Morpholino oligonucleotide-triggered beta-catenin knock- down compromises normal liver regeneration. J Hepatol 2005; 43:132-141.
  11. Hussain SZ, Sneddon T, Tan X, Micsenyi A, Michalopoulos GK, Monga SP. Wnt impacts growth and differentiation in ex vivo liver development. Exp Cell Res 2004;292:157-169.
  12. Micsenyi A, Tan X, Sneddon T, Luo JH, Michalopoulos GK, Monga SP. Beta-catenin is temporally regulated during normal liver de- velopment. Gastroenterology 2004;126:1134 -1146.
  13. Monga SP, Micsenyi A, Germinaro M, Apte U, Bell A. beta-Catenin regulation during matrigel-induced rat hepatocyte differentiation. Cell Tissue Res 2006;323:71-79.
  14. Monga SP, Monga HK, Tan X, Mule K, Pediaditakis P, Michalo- poulos GK. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specifica- tion. Gastroenterology 2003;124:202-216.
  15. Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S, Monga DK, Bell A, Michalopoulos GK, Monga SP. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology 2005;129:285-302.
  16. Inoue Y, Inoue J, Lambert G, Yim SH, Gonzalez FJ. Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis. J Biol Chem 2004;279:44740 - 44748.
  17. Postic C, Magnuson MA. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 2000;26: 149 -150.
  18. Higgins GM, Anderson RM. Experimental pathology of the liver. I. Restoration of the white rat following partial surgical removal. Arch Pathol 1934;12:186 -202.
  19. Ye H, Holterman AX, Yoo KW, Franks RR, Costa RH. Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S phase. Mol Cell Biol 1999;19:8570 -8580.
  20. Staal FJ, Noort Mv M, Strous GJ, Clevers HC. Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 2002;3:63-68.
  21. Loeppen S, Koehle C, Buchmann A, Schwarz M. A beta-catenin- dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. Carcinogenesis 2005;26:239 - 248.
  22. Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995;9:1527-1536.
  23. Stambolic V, Woodgett JR. Mitogen inactivation of glycogen syn- thase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 1994;303:701-704.
  24. Cadoret A, Ovejero C, Terris B, Souil E, Levy L, Lamers WH, Kitajewski J, Kahn A, Perret C. New targets of beta-catenin sig- naling in the liver are involved in the glutamine metabolism. Oncogene 2002;21:8293-8301.
  25. Mankertz J, Hillenbrand B, Tavalali S, Huber O, Fromm M, Schul- zke JD. Functional crosstalk between Wnt signaling and Cdx- related transcriptional activation in the regulation of the claudin-2 promoter activity. Biochem Biophys Res Commun 2004;314: 1001-1007.
  26. Ovejero C, Cavard C, Perianin A, Hakvoort T, Vermeulen J, Godard C, Fabre M, Chafey P, Suzuki K, Romagnolo B, Yamagoe S, Perret C. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology 2004; 40:167-176.
  27. De BK, Brown TL, Suchy FJ. Ontogeny of epidermal growth factor receptor tyrosine kinase in rat liver. Am J Physiol 1991;260: G290 -G298.
  28. Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci 2002;59:627-647.
  29. Moffatt P, Denizeau F. Metallothionein in physiological and phys- iopathological processes. Drug Metab Rev 1997;29:261-307.
  30. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002; 65:166 -176.
  31. Lieber CS. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev 2004;36:511-529.
  32. Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol 2001;281:G1135-G1139.
  33. Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 2001;15:1335-1349.
  34. Debeljak N, Fink M, Rozman D. Many facets of mammalian lanosterol 14alpha-demethylase from the evolutionarily con- served cytochrome P450 family CYP51. Arch Biochem Biophys 2003;409:159 -171.
  35. Schwarz M, Lund EG, Russell DW. Two 7 alpha-hydroxylase en- zymes in bile acid biosynthesis. Curr Opin Lipidol 1998;9:113- 118.
  36. Gonzalez FJ. The use of gene knockout mice to unravel the mechanisms of toxicity and chemical carcinogenesis. Toxicol Lett 2001;120:199 -208.
  37. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid perox- ides in murine nonalcoholic steatohepatitis. J Clin Invest 2000; 105:1067-1075.
  38. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60 -66.
  39. Behrens A, Sibilia M, David JP, Mohle-Steinlein U, Tronche F, Schutz G, Wagner EF. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J 2002;21:1782-1790.
  40. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 1999;96: 5522-5527.
  41. Servillo G, Della Fazia MA, Sassone-Corsi P. Transcription factor CREM coordinates the timing of hepatocyte proliferation in the regenerating liver. Genes Dev 1998;12:3639 -3643.
  42. Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci U S A 2005;102:3389 -3394.
  43. Colletti LM, Green M, Burdick MD, Kunkel SL, Strieter RM. Pro- liferative effects of CXC chemokines in rat hepatocytes in vitro and in vivo. Shock 1998;10:248 -257.
  44. Gallai M, Sebestyen A, Nagy P, Kovalszky I, Onody T, Thorgeirs- son SS. Proteoglycan gene expression in rat liver after partial hepatectomy. Biochem Biophys Res Commun 1996;228:690 - 694.
  45. Kohler C, Bell AW, Bowen WC, Monga SP, Fleig W, Michalopoulos GK. Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration. Hepatology 2004;39:1056 -1065.
  46. Coulouarn C, Derambure C, Lefebvre G, Daveau R, Hiron M, Scotte M, Francois A, Daveau M, Salier JP. Global gene repres- sion in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition. J Hepatol 2005;42:860 -869.

Cited by

Sorted by citations

Authors
Tan, X., Behari, J., Cieply, B., Michalopoulos, G. K., & Monga, S. P. S.
Affiliations
University of Pittsburgh (US)
Corresponding author
Monga, Satdarshan P.S.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2006-11
Volume
131
Issue
5
Pages
1561-1572
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2048711000
Cited by
361
References
1
Citations by year
2026: 8 · 2025: 13 · 2024: 20 · 2023: 13 · 2022: 18 · 2021: 17 · 2020: 19 · 2019: 11 · 2018: 19 · 2017: 21 · 2016: 14 · 2015: 15 · 2014: 19 · 2013: 23 · 2012: 18
FWCI
15.42
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1RO1DK62277)
  • National Institute of Diabetes and Digestive and Kidney Diseases (1 R01 DK62277, R01DK062277)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
Keywords
β-catenin, Wnt/β-catenin signaling, liver growth, liver regeneration, conditional knockout, hepatocyte proliferation, partial hepatectomy, apoptosis, cyclins, liver development, liver homeostasis
MeSH terms
Animals, Cytochrome P-450 Enzyme System, Hepatectomy, Liver, Liver Regeneration, Male, Phenotype, Cadherins, Apoptosis, Mice, Knockout, Proliferating Cell Nuclear Antigen, Cell Proliferation, Wnt Proteins, beta Catenin, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review